We are live on ! Find out more
SCG

Social Capital Group Portfolio holdings

AUM $5.16M
1-Year Est. Return 66.85%
This Fund
S&P 500
This Quarter Est. Return
-23.98%
1 Year Est. Return
-66.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$117M
AUM Growth
Cap. Flow
+$160M
Cap. Flow %
136.84%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 89.02%
2 Financials 10.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PROK icon
1
ProKidney
PROK
$380M
$91.1M 77.68%
+13,273,000
New +$127M
AKLI
2
DELISTED
Akili Inc
AKLI
$13.3M 11.34%
+11,873,000
New +$20.9M
DNAB
3
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$6.44M 5.49%
+640,000
New +$6.36M
DNAD
4
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$6.43M 5.49%
+640,000
New +$6.36M

Similar funds

Social Capital Group's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Social Capital Group, which disclosed 4 positions worth $117M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is ProKidney: 13,273,000 shares worth $91.1M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, followed by Financials.

  • Social Capital Group's largest Q4 2022 buy was ProKidney: 13,273,000 shares worth $91.1M.
  • Social Capital Group's ten largest holdings make up 100% of its $117M portfolio in Q4 2022.
  • Social Capital Group disclosed 4 positions in Q4 2022, its first 13F filing on record.

Based on Social Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.